market access

Market access encompasses the commercial, medical, and policy strategies through which pharmaceutical and medical technology companies secure reimbursement and patient access across major healthcare markets. Dossier development, health economic modelling, and payer engagement strategies are core disciplines. Real-world evidence generation is increasingly required by HTA bodies as a condition of coverage, creating new demands on post-launch evidence plans.